Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
McCawley, Niamh; Clancy, Cillian; O'Neill, Brian D P; Deasy, Joseph; McNamara, Deborah A; Burke, John P.
Dis Colon Rectum
; 59(12): 1200-1208, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27824706
Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.
Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
Rectal Mucinous Adenocarcinoma: MR Imaging Assessment of Response to Concurrent Chemotherapy and Radiation Therapy-A Hypothesis-generating Study.
[Long-Term Survival by Multidisciplinary Treatments in a Non-Curative Resected Case of Rectal Mucinous Carcinoma Occurring 20 Years after Surgery for Rectal Carcinoma].
[Rectal Mucinous Cancer with Submucosal Tumor-Like Morphology Preoperatively Diagnosed Using EUS-FNAB - A Case Report].
Mucinous carcinoma of the rectum: a distinct clinicopathological entity.
Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study.
Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.